Founded Year
2013Stage
Series D | AliveTotal Raised
$141.97MLast Raised
$50M | 2 yrs agoAbout Alzheon
Alzheon is an American clinical-stage biopharmaceutical. The company develops medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. Alzheon was founded in 2013 and is based in Farmingham, Massachusetts.
Alzheon Headquarter Location
111 Speen Street Suite 306
Framingham, Massachusetts, 01701,
United States
508-681-7709
Expert Collections containing Alzheon
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Alzheon is included in 2 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,128 items
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Alzheon Patents
Alzheon has filed 10 patents.
The 3 most popular patent topics include:
- Rare diseases
- Alzheimer's disease
- Cognitive disorders
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/9/2016 | 12/7/2021 | Prodrugs, Neurological disorders, Alzheimer's disease, Psychiatric diagnosis, Rare diseases | Grant |
Application Date | 9/9/2016 |
|---|---|
Grant Date | 12/7/2021 |
Title | |
Related Topics | Prodrugs, Neurological disorders, Alzheimer's disease, Psychiatric diagnosis, Rare diseases |
Status | Grant |
Latest Alzheon News
Apr 16, 2022
APR 15, 2022 | 2:04 PM PDT | BIOCENTURY | FINANCEYEARS AFTER FAILED IPO ATTEMPTS, ALZHEON RAISES $50M ROUND FOR ALZHEIMER’S STUDYBY With Phase III Alzheimer’s trial finally in progress, Alzheon’s new $50M series D arrives four years after first attempt to go publichttps://www.biocentury.com/article/643195/years-after-failed-ipo-attempts-alzheon-raises-50m-round-for-alzheimer-s-study© 2022 BioCentury Inc. All Rights Reserved
Alzheon Web Traffic
Alzheon Rank
When was Alzheon founded?
Alzheon was founded in 2013.
Where is Alzheon's headquarters?
Alzheon's headquarters is located at 111 Speen Street, Framingham.
What is Alzheon's latest funding round?
Alzheon's latest funding round is Series D.
How much did Alzheon raise?
Alzheon raised a total of $141.97M.
Who are the investors of Alzheon?
Investors of Alzheon include National Institute on Aging, Paycheck Protection Program, Ally Bridge Group and ARCH Venture Partners.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.